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Abstract
Background: Frailty indicates accumulated vulnerability of adverse health outcomes in later life. Its robustness in
predicting dependent living, falls, comorbidity, disability, health change, mortality, and health care utilization at older
ages is well-documented. However, almost no studies have ever attempted to examine its robustness in centenarians,
mainly due to data unavailability. This study examines prevalence of frailty in centenarians and its predictive powers on
subsequent mortality and health conditions.
Methods: We use a sample of 4434 centenarians from the 2002, 2005, 2008, and 2011 waves of the Chinese Longitudinal
Healthy Longevity Survey (CLHLS), with elders in three younger age groups 65–79, 80–89, and 90–99 as comparisons.
Frailty is measured by a cumulative deficit index (DI) that is constructed from 39 variables covering physical and cognitive
function, disease conditions, psychological well-being, and other health dimensions. Survival analysis is conducted to
examine how frailty is associated with subsequent mortality at an average follow-up length of 3.7 years (2.6 years for
deceased persons died in 2002–2011 and 7.6 years for survived persons at the 2011 wave). Logistic regressions are
applied to examine how frailty is associated with subsequent physical and cognitive functions, disease conditions, and
self-rated health with an average follow-up length of 3.0 years.
Results: The study reveals that centenarians are frailer than younger elders. The DI scores increase from less than 0.1 at
ages 65–79 to over 0.30 in centenarians. Women are frailer than men at all ages. However, there is a great variation in
frailty among all age groups. We also find that each additional increase of 0.01 score of the DI is associated with 1.6 %
higher mortality risk (95 % CI: 1.014–1.018) in female centenarians and 1.4 % higher mortality risk (95 % CI: 1.010–1.018)
in male centenarians, although these associations are weaker than those in other three younger age groups.
Conclusions: Frailty still plays an important role in determining subsequent health outcomes and mortality in
centenarians.
Keywords: Centenarians, Frailty index, Cumulative deficit index, China, Mortality, Successful aging, Healthy aging,
Healthy longevity, CLHLS
Background
Research on frailty has gained increasing attention in
aging studies and geriatric clinical practice in the past
three decades [1, 2]. Although there is still a debate on
how to define and measure frailty, there is a general
agreement in the field that frailty of the later life reflects
the functional decline of multiple physiological reserves
that limits an elder’s ability to respond to external
stressors [3–6]. Frailty is more than a health outcome
out of some specific diseases or disabilities, but rather a
systemic manifestation of physical and cognitive deficits
that accumulate over the life course [5–8]. Frailty varies
within and between individuals. Researchers have re-
vealed that for an elder, the status of frailty could be dy-
namic, improved or deteriorated at different time periods
[9, 10]; meanwhile it is evidenced that a substantial het-
erogeneity of frailty exists among individuals of old ages,
as the density distribution of frailty varies greatly for elders
at different ages [4, 11].
To date, there are two models to measure frailty: one is
the phenotypic approach and the other is the cumulative
approach [1, 4, 5]. The former defines frailty based on a
set of manifest items, such as weight loss, exhaustion,
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weakness, slowness, or low physical activity, and takes the
appearance of any three conditions as an indication of
frailty [3]; whereas the latter adopts a cumulative deficit
index (DI) or frailty index (FI), which quantifies an indi-
vidual’s proportion of deficits in a cumulative summation
over a variety of psychological, physiological, and func-
tional conditions [7, 10]. In comparison with the pheno-
typic approach, the DI emphasizes the aggregate (or
systemic) deterioration in psychophysiological perform-
ance [7] rather than focusing on the presence of a specific
set of conditions. Numerous studies have shown that the
DI is a robust predictor for health and health-related out-
comes in later life such as dependent living, falls, comor-
bidity, disability, health change, mortality, and health care
utilization, net of various confounders; and this important
index has been applied as an effective tool among geriatri-
cians, clinicians, and other practitioners for public health
monitoring and intervention [2, 4, 5, 11, 12].
Frailty in centenarians has recently arisen as one of the
frontline topics in the field of frailty studies [4, 13]. With
the extraordinary longevity, centenarians make up a spe-
cial segment of the elderly population. Studies on this
group of people have been underscored in gerontology
and geriatrics because of the rapidly booming size of cen-
tenarians in the world population for the recent decades
[14–16]. It may not be appropriate to take it for granted
that centenarians necessarily follow a general trajectory of
health decline at old ages, as this group has been through
significant mortality selection. In fact, some scholars argue
that centenarians could be relatively healthy [17, 18]; how-
ever, more studies have refuted that centenarians tend to
be the most vulnerable and sickest in terms of physical
and physiological function, and other reserve capacities
[19, 20]. Regardless of the debate as above, researchers
tend to acknowledge that a large variation exists among
centenarians in physical/cognitive functions, disease con-
ditions as well as psychological well-being [17, 19, 21, 22].
Due to these characteristics of centenarians, to examine
the prevalence and health-predictive power of frailty is
warranted for this special age group.
Are centenarians necessarily frailer than younger elders?
How effectively frailty could predict health outcomes in
this oldest age group? To our knowledge, almost no stud-
ies in the current literature have ever attempted to address
these questions, which is mainly due to data unavailability.
This study chooses the largest centenarian samples in the
contemporary world from the 2002, 2005, 2008, and the
2011 waves of the Chinese Longitudinal Healthy Longev-
ity Survey (CLHLS) to investigate frailty among Chinese
centenarians. Following a cumulative deficit approach, this
study adopts the measurement of the DI to fulfill two spe-
cific research goals: 1) to describe the prevalence of frailty
in Chinese centenarians in comparison with younger el-
ders; and 2) to examine frailty as a predictor of subsequent
mortality and health outcomes among centenarians in
comparison with younger elders.
Methods
Study sample
The dataset comes from the 2002, 2005, 2008, and 2011
waves of the ongoing Chinese Longitudinal Healthy Lon-
gevity Survey (CLHLS). The first two waves of the CLHLS
in 1998 and 2000 are dropped because some variables to
be used in construction of the DI are not available. One
purpose of each wave of the CLHLS is to interview all
centenarians in a randomly selected half of the counties/
cities in 22 Han-ethnicity dominant provinces in Main-
land China. The 22 provinces cover about 82 % of the
total population in China in 2010. Age of each centenarian
in the CLHLS is validated from various sources available,
including birth certificate, genealogical documents, house-
hold booklet, and ages of their children and siblings. For
each centenarian interviewed, roughly one nearby re-
spondent from each of three age groups (65–79, 80–89,
and 90–99) with predesignated age and sex is randomly
chosen to be interviewed based on a random code
assigned to the centenarian. The nearby respondent could
come from a neighboring village or town, depending on
availability of the person with predesignated age and sex.
All information is obtained through in-home interviews.
Starting in the 2008 wave, in-depth interviews were con-
ducted in the seven longevity areas (the number increased
to eight in the 2011 wave and the 2014 wave). Figure 1
presents the spatial distribution of the sample in the 2008
wave. Detailed sampling procedures can be found in else-
where [23]. Systematic assessments of the accuracy of age
reporting, the randomness of attrition, and the reliability,
validity, and consistency of numerous measures show that
the data quality of the CLHLS is high [23].
For robustness of the results, we pool the 2002, 2005,
and 2008 waves together to estimate the prevalence of
frailty and to examine how the DI of the respondents at
these three waves are associated with subsequent mor-
tality and health outcomes in 2005, 2008 and 2011 waves,
respectively. As we focus on mortality and health out-
comes at subsequent waves, we only include those respon-
dents who have at least one follow-up in 2005, 2008, or
2011. Overall, about 7500 respondents do not have any
follow-up, of which 1430 are centenarian. In sum, for the
mortality analysis, it has a total number of 4434 valid cen-
tenarians with 3557 women and 877 men, who make up
6541 observations with 5188 from women and 1353 from
men. In three comparison groups with ages 65–99, the
corresponding number for the total valid respondents is
14,051 with 7309 women and 6742 men, contributing
27,619 observations with 14,343 from women and 13,276
from men over the study period. In the health outcome
analyses, only those who were healthy at the 2002, 2005,
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or 2008 wave were included. The valid number of sample
thus varies by specific health outcome variable.
Ethics approval
Duke University Medical Health System’s Institutional Re-
view Board (IRB), the National Bureau of Statistics of China,
and the Ethical Committee of Social Science Division of Pe-
king University reviewed and approved ethics for this study.
A written consent is obtained from each of all CLHLS par-
ticipants except some rare cases when participants who are
not able read or write. In these occasions, a consent form is
read by the interviewer and signed by a witness.
The CLHLS datasets are publicly available at http://cen-
terforaging.duke.edu/data-downloads. Researchers can ob-
tain the datasets after sending a data user agreement to
the CLHLS team.
Measurements
Cumulative Deficit Index (DI)
Following the established research [4, 5, 24], we generate
the DI for each elder with a score ranging from 0 to 1,
which is measured by unweighted counts of the number
of deficits divided by the total number of possible deficits
(40 deficits from total 39 indicators). These 39 indicators
include self-reported health status, cognitive functioning,
disabilities in activities of daily living (ADL) and instru-
mental ADL, auditory and visual ability, depression, heart
rhythm, chronic conditions (e.g., stroke, diabetes, heart
diseases, lung diseases, etc.), and serious illness measured
by being hospitalized or bedridden. If the number of ser-
ious illness is more than one in the past 2 years, an add-
itional deficit score is added. More details about the
measurement of the DI used in the present study can be
found in the work of Gu and colleagues [4].
Mortality risk
Mortality risk (or hazard risk) is the dependent variable in
survival analyses, which is measured by survival status and
duration of exposure to death. The survival status is mea-
sured by whether a respondent interviewed in the 2002,
2005, or 2008 wave died or survived at the 2011 wave. The
exposure duration for a survivor is measured by number of
days from the interview date in the wave of 2002, 2005, or
2008 to the interview date in 2011. For those who died be-
fore the 2011 wave, the exposure time is measured by the
time interval between date at death and the date at the
interview when a respondent was first interviewed in either
2002, 2005, or 2008. The date at death was collected from
officially issued death certificates whenever available,
otherwise the next-of-kin and local residential committees
were consulted when a death certificate was not available.
The average of follow-up length from all samples used in
this set of analysis is 3.7 years, with 2.6 years for deceased
persons who died in the period of 2002–2011 and 7.6 years
for survived persons at the 2011 wave who recruited in ei-
ther 2002, 2005, or 2008. The data quality of mortality in
the CLHLS has been proved to be high [23].
Health outcomes
Physical function, cognitive function, chronic disease condi-
tions, self-rated health, and self-rated life satisfaction are
five health outcomes used for analysis of the associations
between the DI and health outcomes. Cognitive function is
measured by a Chinese version of the Mini-mental Status
Examination (MMSE) that includes six domains of cogni-
tion (orientation, reaction, calculation, short memory, nam-
ing, and language) with a total score of 30: a centenarian is
considered as cognitively unimpaired if his or her MMSE
score is 24 or over [23]. Given a low level of educational
Fig. 1 Spatial distribution of the respondents in the 2008 wave
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attainment of most elderly Chinese, alternative criteria are
applied to respondents with different levels of education to
test the sensitivity of different cut-off points for defining of
cognitive impairment, and very similar results are produced
(not shown but available upon request). The Chinese ver-
sion of MMSE used in the CLHLS is culturally translated
from the internationally standard version of the MMSE
questionnaire [25]. Its validity and reliability are carefully
tested in pilot surveys and are verified in each wave of the
CLHLS [23, 26]. Physical function in terms of ADL is
measured by whether a respondent needs any assistance
in performing six daily activities, namely bathing, dressing,
indoor transferring, toileting, eating, and continence. A re-
spondent is considered as ADL independent if he or she
did not need any assistance in performing all six tasks at
the time of the surveys. The CLHLS adopts a list of twenty
diseases (e.g., heart diseases, stroke, diabetes, hyperten-
sion, cancers, cataracts, Parkinson’s disease) to measure
comorbidity; an individual is considered as having no
chronic conditions if he or she did not self-report any of
these twenty disease conditions at the time of the surveys.
About 95 % of these self-reported diseases are confirmed
by a physician or medical professional. The prevalence of
each major disease is comparable to other nationwide sur-
veys [23]. Self-rated health and self-rated life satisfaction
are classified as good/very good versus others. We have
also tested other categorizations for these two variables,
and the findings are the same.
Covariates
To obtain the robust results, we follow a common practice
in the literature [4, 27] to control for several sets of covari-
ates, which include demographics, socioeconomic status,
and health practice. Demographics includes age, residence
(urban vs. rural), ethnicity (Han vs. non-Han), and coresi-
dence with children (yes vs. no). Sex is not considered as a
covariate since all analyses are stratified by sex. Socioeco-
nomic status includes years of schooling (0, 1–6, and 7+),
lifetime primary occupation (professional/administration
vs. others), economic independence (having a retirement
wage/pension and/or own earnings vs. no), and family
economic condition in comparison with others (rich/very
rich vs. others). Health practice is measured by currently
smoking (yes vs. no), currently consuming alcohol (yes vs.
no), and regularly doing exercise at present (yes vs. no).
Analytical strategy
The analyses involve two sets of methods and are always
stratified by sex and age group with centenarians as the
study group and three younger age groups 65–79, 80–
89, and 90–99 as comparison. The first set of method is
survival analyses, which examine whether the DI is asso-
ciated with subsequent mortality risks among centenar-
ians. Such associations are next compared with those of
other age groups of 65–79, 80–89, and 90–99. The Wei-
bull parametric survival function is applied because some
variables violate the proportionality assumption of the
Cox proportional hazard model. To improve its robust-
ness, we control for demographics, socioeconomic status,
and health practice. Except for sex, education, primary life
occupation, all other variables are considered as time-
varying variables. In other words, all longitudinal informa-
tion of related variables at each follow-up wave is used in
the analyses.
The second set of method is logistic regression ana-
lyses, which investigate how the DI is associated with
each of five major health outcomes at the subsequent
wave. The average lengthen of follow-up is 3.0 years. In
this set of analyses, in order to capture changes of health
at follow-up, only those who are cognitively unimpaired,
ADL independent, free of chronic disease conditions,
good self-rated health, or good self-rated life satisfaction
at baseline waves are included. In these logistics regres-
sion models, demographics, socioeconomic status, and
health practice are controlled for.
All analyses are performed using Stata version 13.1. As
the sample weight of the CLHLS is purely based on the
distribution of single year of age, sex, and urban–rural
residence of population in the survey area and these
three variables are either stratified (i.e., sex) or con-
trolled for in the models, all regression analyses are not
weighted [4]. Supplementary analyses confirm that the
results in regressions from the weighted sample are very
close to those from the unweighted. However, in de-
scription of the DI score, the sample weight is applied.
Results
The sample characteristics are presented in Table 1. Figure 2
uses box plots to present the median and quartile percen-
tiles of the DI scores for centenarians by sex in comparison
with other three age groups in the pooled dataset. Figure 3
shows the mean and 95 % confidence intervals of the DI
scores by sex for four age groups. Results in Figs. 2 and 3
indicate that centenarians tend to have a higher DI score,
with 0.356 for women and 0.303 for men. The mean DI
scores of other three comparison groups for women are
0.091 for ages 65–79, 0.178 for ages 80–89, and 0.271 for
ages 90–99, respectively. The corresponding figures of for
men are 0.072, 0.139, and 0.218, respectively. Figure 4 re-
ports the density distribution of the DI scores for centenar-
ians and other three age groups by sex in the pooled
dataset. This distribution is very similar to those in Gu
and colleagues [4], indicating that in comparison with
younger age groups, most centenarians have a higher DI
score. Figure 5 shows that the variance of the DI scores in-
creases with age up to ages 95–99 and then slightly de-
clines in centenarians with great fluctuations, regardless of
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Table 1 Sample description of the CLHLS, 2002–2008, pooled, unweighted
Centenarians Ages 65–99
Variables Women Men Women Men
# of respondents (observations) 3,557 (5,188) 877 (1,353) 7,309 (14,343) 6,742 (13,276)
Mean DI score (*100) 36.9 30.8 18.1 13.3
Health outcomes
% ADL independent 42.6 52.0 80.9 87.4
% Cognitively unimpaired 18.3 33.5 60.7 76.8
% Having no chronic diseases 44.4 44.6 41.3 43.1
% Self-rated good health 35.6 43.7 45.9 50.8
% Self-rated good life satisfaction 46.2 52.5 56.2 56.2
% Death from 2002 to 2011/12 79.3 82.2 36.0 35.8
Covariates
Mean age 101.4 101.3 82.7 80.8
% Urban 36.8 43.7 36.4 37.8
% Han ethnicity 94.6 93.3 93.8 94.3
% Coresidence with children 87.5 80.2 65.3 55.2
% 0 years of schooling 92.5 57.0 79.4 36.4
% 1–6 years of schooling 6.2 34.4 16.5 45.9
% 7+ years of schooling 1.3 8.6 4.1 17.7
% White collar job 0.8 8.2 3.2 13.2
% Economic independence 2.4 23.7 23.8 45.6
% Good family economic condition 13.6 16.1 14.4 16.5
% Smoking at present 4.9 20.9 7.4 38.4
% Alcoholic consuming at present 12.5 24.3 9.3 33.9
% Doing regular exercise at present 13.9 26.7 24.8 36.0
Note: (1) DI refers to the cumulative deficit index. (2) The samples and observations only include those who were aged 65–105 at their first interviews in the 2002,
2005 and 2008 waves of the CLHLS and had at least one follow-up interview. (3) Except for the proportion of death, which is calculated based on the whole study
period, five health outcomes are measured at either 2002, 2005, or 2008 wave of the CLHLS
Fig. 2 Distribution of median and quartile percentile of cumulative deficit index by age group and sex, CLHLS 2002–2008, pooled, weighted
Gu and Feng BMC Geriatrics  (2015) 15:159 Page 5 of 11
Fig. 3 Mean scores of DI and their 95 % CIs by age group and sex, CLHLS 2002–2008, pooled, weighted
Note: frequency distribution of DI is based on the observations in the 2002, 2005, and 2008 waves.
Fig. 4 Distribution of the cumulative deficit index by age group and sex, CLHLS 2002–2008, pooled, weighted
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sex This indicates that there exists a large variation of the
DI scores in centenarians.
Figure 6 reports hazard ratios of mortality, adjusting
for demographics, socioeconomic status, and health
practice. In centenarians, each additional 0.01 increase
in the DI score is associated with 1.6 % and 1.4 % higher
hazard ratios of mortality in women and men, respect-
ively, lower than those in other age groups. Although
Fig. 6 reveals a diminishing association between the DI
score and mortality risk over ages, it is clear that the DI
still maters to mortality in centenarians.
Table 2 presents sex-specific odds ratios of subsequently
being in a poor health condition for each additional 0.01
increase in the DI score, in presence of controls such as
demographics, socioeconomic status, and health practice.
The results clearly show that in centenarians, a higher DI
score is associated with greater risks of being disabled,
cognitively impaired, poor in self-rated health, and poor in
self-rated life satisfaction. The increased odds ratios are
relatively larger in men than in women. Such negative as-
sociations are also observed in other age groups. There
are a couple of exceptions, however. For example, the as-
sociation between the DI scores and chronic diseases are
not significant at p < 0.05 for centenarians, and this is also
the case for women in age groups of 80–89 and 90–99.
Discussion
Frailty has become one of the key topics in the aging
study since the 1980s [28, 29]. Due to the capacity of
reflecting accumulative health risks in old ages, this
measurement holds important values in research and
practice, especially for the public health system to face
the unprecedented trend of population aging [30, 31].
However the current literature has not adequately stud-
ied this important measurement in centenarians [13]. In
particular, the prevalence and mortality/health predictive
Fig. 5 Variance of DI by age and sex, CLHLS 2002–2008, pooled, weighted
Fig. 6 Mortality hazard ratios of frailty index score (*100) in centenarians in comparison with non-centenarians by sex, the CLHLS 2002–2011,
pooled, unweighted
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power of frailty are yet unexplored for this group of
population with extraordinary longevity.
This study makes an initial effort to fulfill such a research
gap and it has some important strengths. First, unlike most
centenarian studies which hold relatively small sample sizes
[5, 8], we have employed the world’s largest sample of cen-
tenarians, as guarantees the robustness of the analysis. Sec-
ond, our study samples come from the mainland China,
which has the world’s largest oldest-old population since
the 1990s and up until the end of the 21st century [32]. In
comparison with the Western literature, research on frailty
is still scarce in developing countries. With regard to
China, there is an urgent call to better understand health-
related issues such as frailty, not only because the Chinese
population is aging rapidly, but also because the Chinese
eldercare system is experiencing profound changes [33].
This study provides robust evidence showing that cen-
tenarians are frailer in average than their younger elderly
counterparts. The distribution of the DI scores over ages
in this study is almost similar to those reported in one
previous study on China [4]. The mean DI score over
younger ages (before age 100) as reported in the study is
also similar to those from other populations, such as in
the U.S. [5, 7] and in a pooled sample from a few devel-
oped countries [10].
Although centenarians appear to be the frailest among
all elders, this study reveals a substantial heterogeneity
within this group, at least greater than those below age 90.
The DI score distribution of centenarians as observed in
the study well echoes the mathematical models of frailty as
proposed by Rockwood and colleagues [6, 34, 35], who
argue that the distribution of the frailty index tends to
change from a gamma distribution to approximate a nor-
mal one with advance of age. Such a distributional change
has been justified from a biological perspective. That is,
aging could be considered as a consequence of system
Table 2 Odds ratios of being in a poor health condition at the subsequent wave for the DI by age and sex, CLHLS 2002–2011,
pooled, unweighted
Women Men
From ADL independent to ADL disable
Ages 100+ (291/125) 1.035 (1.021–1.049)*** 1.048 (1.021–1.077)***
Ages 90–99 (743/679) 1.036 (1.026–1.045)*** 1.036 (1.025–1.048)***
Ages 80–89 (1480/1633) 1.045 (1.036–1.054)*** 1.043 (1.033–1.053)***
Ages 65–79 (3055/3390) 1.058 (1.045–1.070)*** 1.066 (1.053–1.080)***
From cognitively unimpaired to impaired
Ages 100+ (550/159) 1.024 (1.003–1.046)* 1.039 (1.011–1.069)**
Ages 90–99 (1128/833) 1.013 (1.008–1.031)** 1.035 (1.022–1.048)***
Ages 80–89 (1838/1794) 1.011 (1.003–1.019)** 1.026 (1.017–1.035)***
Ages 65–79 (3351/3471) 1.020 (1.011–1.030)*** 1.035 (1.025–1.046) ***
From no chronic diseases to having 1+ chronic diseases
Ages 100+ (462/113) 1.007 (0.995–1.018) 1.024 (0.998–1.050) +
Ages 90–99 (649/487) 1.009 (1.000–1.019) + 1.019 (1.005–1.032)**
Ages 80–89 (848/808) 1.010 (0.999–1.021) + 1.021 (1.007–1.034)**
Ages 65–79 (1347/1481) 1.022 (1.001–1.040)* 1.027 (1.008–1.047)**
From good self-rated health to poor self-rated health
Ages 100+ (465/144) 1.029 (1.018–1.039)*** 1.051 (1.026–1.077)***
Ages 90–99 (749/593) 1.022 (1.014–1.030)*** 1.027 (1.016–1.038)***
Ages 80–89 (1105/1083) 1.033 (1.025–1.041)*** 1.039 (1.029–1.049)***
Ages 65–79 (1738/1959) 1.043 (1.033–1.054)*** 1.058 (1.047–1.070)***
From good self-rated life satisfaction to poor self-rated
life satisfaction
Ages 100+ (582/151) 1.019 (1.007–1.030)** 1.051 (1.023–1.080)***
Ages 90–99 (931/652) 1.016 (1.001–1.025)*** 1.011 (0.999–1.021) +
Ages 80–89 (1315/1218) 1.011 (1.003–1.018)** 1.005 (0.996–1.014)
Ages 65–79 (1979/2073) 1.016 (1.006–1.025)** 1.022 (1.012–1.032)***
Note: (1) Odds ratios in this table are adjusted for demographics, socioeconomic status, and health practice. (2) numbers in parentheses at the first column are
number of observations of women and men included in the regression models, respectively. (3) + p < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001
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redundancy: with deficits being accumulated through the
life course, the exhaustion of redundancy at the ending
years will lead to the emergence of a normal distribution
in frailty [36]. This study provides empirical evidence to
supporting the models proposed by Rockwood and
colleagues. With a couple of exceptions [4, 37], previ-
ous work has never examined frailty distribution for
centenarians.
Furthermore, we find that women are frailer than their
male counterparts, and this sex disparity gets smaller at
younger ages. Such a finding is in line with what has
been found in other populations [2, 5, 7, 10, 38]. We
speculate that the higher level of frailty in women might
be due to a combination of higher incidence, longer du-
rations (i.e., low recovery), and lower severity of illnesses
[39]. The literature of aging studies has long recognized
a gender paradox in health and mortality, and it is ar-
gued that gender differences in genetic and acquired
risks, immune system responses, hormones, disease pat-
terns and prevention, and health-reporting behaviors
may explain the poorer health and lower mortality of
women than men [40]. Due to unavailability of data and
research on frailty in centenarians, we are not able to
make comparisons between China and other countries
to examine whether the sex difference in the DI scores
persists. However, two recent studies focusing on near-
centenarians and centenarians show that women are
frailer than men in terms of phenotypic frailty [41] and
accumulative deficit index [13]. More studies are clearly
needed to further verify the gender difference.
One critical finding in this study is that the DI score is
still a valid predictor of mortality among centenarians.
Previous studies have argued that the DI tends to have a
better predictive ability of mortality than the phenotype
measurement [42], and according to the review by Bouil-
lon et al. [1], using the DI or the frailty index, the odds
ratios of mortality range from 1.57 to 10.53 for frail indi-
viduals relative to non-frail individuals. However, to our
knowledge, how the DI could be predictive of mortality
among centenarians has not been investigated. Our re-
sults for the first time show that the DI still maintains
predictive of mortality in this very old aged population,
although its power is not as strong as those in younger
cohorts. Such a finding is reasonable. On the one hand,
the DI reflects a universal feature of the aging process,
in which physical, psychological, and social deficits accu-
mulate over time; and its predictive power over adverse
health outcomes is independent of chronological age [5].
Thus the basic principle of the DI in health prediction
that “people with more things wrong are more like to
suffer an adverse event” [6:723] should be applied to all
human beings, regardless of how old the chronological
age is. On the other hand, at the extremely old ages such
as those of centenarians, the heterogeneity of frailty is
often greater than that of younger ages due to mortality
deceleration among centenarians [43, 44], therefore the
accruement of each deficit in the DI may gradually lose
its power in mortality prediction.
Besides mortality, this study also finds out that the DI
is a valid measure in predicting important health out-
comes in centenarians such as cognitive impairment,
ADL disability, poor self-reported health, and poor self-
reported life satisfaction. The only exception is comor-
bidity, which is likely due to the fact that comorbidity is
prevalent at old ages. Moreover, the underreport of dis-
eases and conditions in old ages, which is quite likely in
China, especially its rural areas, could be another pos-
sible explanation. We consider that some Chinese eld-
erly people possibly do not know that they have diseases
due to the underdeveloped local health service system
and poor health literacy. In addition, the preference on
traditional Chinese medicine may also be a barrier for
potential patients to seek help from a physician [45, 46].
Nevertheless, we think the data quality of disease report-
ing in the CLHLS may not bring in major biases in the
estimation in that the prevalence of major diseases re-
ported in the CLHLS is indeed comparable to a few
other nationwide surveys in China [23]. It is worth not-
ing that frailty loses its predictive power on comorbidity
in women of 80–89 and 90–99. More research is needed
to shed the lights on such issues with further improving
data accuracy of chronic conditions in developing coun-
tries such as China.
Our study has some important implications in both
public health and clinical practices. With the life expect-
ancy being prolonged, the current challenge of the world
population is to achieve healthier survival at old ages. To
identify, avoid, delay, and reverse frailty at old ages could
make up an effective way of preventing adverse health
outcomes and improving the quality of life of older per-
sons. Nevertheless, to fully accommodate frailty in the
clinical practices still requires further transformation of
the current medical system, which has been long institu-
tionalized around single-system illness [34]. Meanwhile,
there is still a long way for the public health system in-
corporating the notion of frailty to monitor and manage
the population health beyond merely targeting specific
diseases and conditions, although the gain appear to be
substantial [47]. Through confirming the validity of the DI
in predicting negative health outcomes in centenarians,
our study supports the application of this important meas-
urement for the full spectrum of old ages. In this sense,
this study contributes empirical evidence to supporting
the use of the frailty measurement in policy and clinical
practices, which could enhance health agencies to better
educate people to prepare for the catastrophic negative
events in later life. Moreover, our finding on the great het-
erogeneity of frailty among centenarians deserves special
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attentions. As centenarians are often taken as a symbol of
successful aging, our findings urge future studies to ex-
plore factors responsible for the substantial health dispar-
ity in this very old age group. In particular, the non-frail
centenarians may provide a key for us to understand how
to achieve healthy longevity.
Our study has some limitations. For example, we only
tested one specific construct of the DI, which is based on
39 indicators. The health predictive power may vary if dif-
ferent variables are used in constructing the DI. Thus
more studies are definitely warranted to examine the val-
idity of the DI in centenarians by using different measures.
However, from our point of view, it is quite unlikely for
the other constructs of the DI to have outcomes against
the findings of the present study because as long as the in-
ventory of variables includes main domains of the DI,
such as disability, functional limitation, cognitive impair-
ment, psychological distress, and chronic diseases, the re-
sults are mostly likely to be similar [4].
Conclusions
Centenarians appear to be the frailest among all elders,
yet within this group there exists a large heterogeneity in
frailty. Women centenarians are frailer than their male
counterparts, and the sex disparity is smaller in younger
age groups. For centenarians, frailty when meaured by the
DI score still plays an important role in affecting mortality,
cognitive impairment, ADL disability, poor self-reported
health, and poor self-reported life satisfaction, although
the predictive powers of the DI are not as strong as those
in younger cohorts. Our findings suggest that to identify,
avoid, delay, and reverse frailty at old ages could be an ef-
fective way to prevent adverse health outcomes and to
improve the quality of life of older persons, and to under-
stand how elders maintain not frail may provide a key to
understanding how to achieve healthy longevity.
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